Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Science 37 revenue
Science 37's revenue is $15.4 million.
What is Science 37's revenue?
- Science 37's revenue growth from 2021 to 2023 is 22.35%.
- Science 37 has 337 employees, and the revenue per employee ratio is $45,551.
- Science 37's peak quarterly revenue was $14.1M in 2023(q3).
- Science 37 peak revenue was $19.3M in 2022.
- Science 37 annual revenue for 2022 was 19.3M, 53.62% growth from 2021.
- Science 37 annual revenue for 2023 was 15.4M, -20.36% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
Science 37 historical revenue
Science 37's peak revenue was $19.3M in 2022. The peak quarterly revenue was $14.1M in 2023(q3).
Science 37's revenue increased from $12.5m in 2021 to $15.4M currently. That's a 22.35% change in annual revenue.
Science 37 annual revenue
Science 37 annual revenue over time
| Fiscal year / year | Science 37 revenue |
|---|---|
| 2021 | $12.5M |
| 2022 | $19.3M |
| 2023 | $15.4M |
Science 37 jobs nearby
Do you work at Science 37?
Did Science 37 meet its revenue projections?
Science 37 financing
Science 37 received early financing of $6.5M on 2015-10-20.
| Series | Round size | Date |
|---|---|---|
| Series A | $6.5M | 10/2015 |
| Series B | $31M | 10/2016 |
| Series C | $35M | 04/2017 |
| Series D | $35M | 01/2019 |
| Series Unknown | $40M | 08/2020 |
| Post Ipo Equity | $200M | 10/2021 |
Science 37 investors
| Investors | Security type |
|---|---|
| dRx Capital | Series A |
| Lux Capital | Series A |
| Arthur Iinuma | Series A |
| Redmile Group | Series B |
| dRx Capital | Series B |
| Lux Capital | Series B |
| Sanofi Ventures | Series B |
| Arthur Iinuma | Series B |
| Glynn Capital Management | Series C |
| Redmile Group | Series C |
| dRx Capital | Series C |
| Lux Capital | Series C |
| Sanofi Ventures | Series C |
| GV | Series C |
| Amgen Inc. | Series C |
| Redmile Group | Series D |
| Glynn Capital Management | Series D |
| dRx Capital | Series D |
| Lux Capital | Series D |
| GV | Series D |
| PPD, Inc. | Series D |
| Novartis | Series Unknown |
| LifeSci Advisors | Series Unknown |
| Redmile Group | Series Unknown |
| Glynn Capital Management | Series Unknown |
| Lux Capital | Series Unknown |
| Sanofi Ventures | Series Unknown |
| GV | Series Unknown |
| Amgen Inc. | Series Unknown |
| PPD, Inc. | Series Unknown |
| Mubadala Capital Ventures | Series Unknown |
| RTW INVESTMENTS LP | Post Ipo Equity |
| LifeSci Advisors | Post Ipo Equity |
| Lux Capital | Post Ipo Equity |
| Samsara BioCapital | Post Ipo Equity |
| BlackRock, Inc. | Post Ipo Equity |
| Surveyor Capital | Post Ipo Equity |
| Mubadala Capital Ventures | Post Ipo Equity |
| Redmile Group | Post Ipo Equity |
| RS Investments | Post Ipo Equity |
| dRx Capital | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| Casdin Capital | Post Ipo Equity |
| PURA VIDA INVESTMENTS LLC | Post Ipo Equity |
| PPD, Inc. | Post Ipo Equity |
Search for jobs
Science 37 highest paying jobs
Zippia gives an in-depth look into the details of Science 37, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Science 37. The employee data is based on information from people who have self-reported their past or current employments at Science 37. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Science 37. The data presented on this page does not represent the view of Science 37 and its employees or that of Zippia.
Science 37 may also be known as or be related to Science 37, Science 37 Inc. and Science 37, Inc.